BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2228558)

  • 21. Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum.
    Karp CL; Turco SJ; Sacks DL
    J Immunol; 1991 Jul; 147(2):680-4. PubMed ID: 2071901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The current aspects of seroepidemiological research in combined foci of leishmaniasis].
    Goncharov DB; Saf'ianova VM; Gracheva LI
    Med Parazitol (Mosk); 1993; (1):39-42. PubMed ID: 8336651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation between canine cutaneous and visceral leishmaniasis by the detection of immunoglobulin G specific for Leishmania (Viannia) braziliensis and Leishmania (Leishmania) chagasi antigens using flow cytometry.
    Santiago Mde A; Ribeiro FC; Mouta-Confort E; Nascimento LD; Schubach Ade O; Madeira Mde F; Bertho AL
    Vet Parasitol; 2008 Jul; 154(3-4):341-6. PubMed ID: 18462885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An indirect immunoperoxidase assay for rapid serodiagnosis of visceral leishmaniasis.
    Jain A; Agrawal M; Tiwari V
    Indian J Exp Biol; 1994 Nov; 32(11):822-5. PubMed ID: 7896312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid screening with a recombinant antigen (rK39) for diagnosis of visceral leishmaniasis using dipstick.
    Qu JQ; Guan LR; Shulidan I; Zuo XP; Chai JJ; Chen SB; Kawazu S; Katakura K; Matsumoto Y; Reed SG; Chang KP
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(3):155-8. PubMed ID: 12567693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoblot analysis of the antibody response to antigens of Leishmania donovani in Indian kala-azar.
    Salotra P; Raina A; Negi NS
    Br J Biomed Sci; 1999; 56(4):263-7. PubMed ID: 10795370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Host humoral immune response to Leishmania lipid-binding protein.
    Maache M; Azzouz S; Diaz de la Guardia R; Alvarez P; Gil R; de Pablos LM; Osuna A
    Parasite Immunol; 2005 Jun; 27(6):227-34. PubMed ID: 16048642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-leishmanial polyclonal antibodies to assess the performance characteristics of leishmanial antigen detection ELISA.
    Azazy AA; Al-Shibani LA; Mohammad Ael-S
    J Egypt Soc Parasitol; 2008 Dec; 38(3):1027-36. PubMed ID: 19209783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occurrence of autoantibodies to intermediate filament proteins in human visceral leishmaniasis and their induction by experimental polyclonal B-cell activation.
    Böhme MW; Evans DA; Miles MA; Holborow EJ
    Immunology; 1986 Dec; 59(4):583-8. PubMed ID: 3492440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis.
    Jaffe CL; Rachamim N; Sarfstein R
    J Immunol; 1990 Jan; 144(2):699-706. PubMed ID: 2295807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevalence of anti-Leishmania antibodies in parenteral drug addicts. Yield value of 2 study techniques].
    Gutiérrez J; Maroto MC; Piédrola G; Higuera A
    Med Clin (Barc); 1993 Feb; 100(5):168-70. PubMed ID: 8450694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical value of anti-live Leishmania (Viannia) braziliensis immunoglobulin G subclasses, detected by flow cytometry, for diagnosing active localized cutaneous leishmaniasis.
    Rocha RD; Gontijo CM; Elói-Santos SM; Teixeira-Carvalho A; Corrêa-Oliveira R; Ferrari TC; Marques MJ; Mayrink W; Martins-Filho OA
    Trop Med Int Health; 2006 Feb; 11(2):156-66. PubMed ID: 16451339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibody identification of Leishmania tropica from Sudanese mucosal leishmaniasis.
    Mohammed el-A ; Wright EP
    Trop Med Parasitol; 1987 Mar; 38(1):34-6. PubMed ID: 3299657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis.
    Garg R; Gupta SK; Tripathi P; Hajela K; Sundar S; Naik S; Dube A
    Vaccine; 2006 Apr; 24(15):2900-9. PubMed ID: 16448729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin.
    Mukherjee M; Bhattacharyya A; Duttagupta S
    Med Sci Monit; 2002 Apr; 8(4):BR117-22. PubMed ID: 11951057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Determination of circulating antibodies in cutaneous leishmaniasis by immunofluorescence test].
    Scuderi G; Massimino SD; Palazzolo A; Garozzo S
    G Ital Dermatol Venereol; 1990 Apr; 125(4):131-4. PubMed ID: 2228038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of antileishmanial IgG antibodies and Leishmania-specific antigens in sera from Yemeni patients with visceral leishmaniasis.
    Azazy AA; Nasher ST; Ishaq A; Bin-Muhanna M; Chance ML
    Ann Trop Med Parasitol; 2003 Oct; 97(7):689-95. PubMed ID: 14613628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Species and stage specificity of Leishmania donovani antigens.
    White AC; Hanham C
    J Parasitol; 1991 Feb; 77(1):142-50. PubMed ID: 1704058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leishmania major: solid phase radioimmunoassay for antibody detection in human cutaneous leishmaniasis.
    Rosen G; Londner MV; Greenblatt CL; Morsy TA; el-On J
    Exp Parasitol; 1986 Aug; 62(1):79-84. PubMed ID: 3720902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of the direct agglutination test and enzyme-linked immunosorbent assay in the sero-diagnosis of leishmaniasis in the Sudan.
    el Safi SH; Evans DA
    Trans R Soc Trop Med Hyg; 1989; 83(3):334-7. PubMed ID: 2617579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.